Article info
PDFExtended report
Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women
- Correspondence to:
Dr J A Stakkestad, CECOR AS, Nygårdsveien 6, PO Box 1364, Gard 5507, Haugesund, Norway;
jacobas{at}cecor.no
Citation
Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women
Publication history
- Accepted February 3, 2003
- First published September 12, 2003.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2003 by Annals of the Rheumatic Diseases